Scott McMeekin
Overview
Explore the profile of Scott McMeekin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1052
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dhandapani R, Mitiche I, McMeekin S, Mallela V, Morison G
Entropy (Basel)
. 2021 Dec;
23(12).
PMID: 34945873
This paper presents a new approach for denoising Partial Discharge (PD) signals using a hybrid algorithm combining the adaptive decomposition technique with Entropy measures and Group-Sparse Total Variation (GSTV). Initially,...
2.
Chakraborty P, Mustafi S, Xiong X, Dwivedi S, Nesin V, Saha S, et al.
Nat Commun
. 2017 May;
8:14634.
PMID: 28530221
Cancer cells actively promote aerobic glycolysis to sustain their metabolic requirements through mechanisms not always clear. Here, we demonstrate that the gatekeeper of mitochondrial Ca uptake, Mitochondrial Calcium Uptake 1...
3.
Wang Y, Thai T, Moore K, Ding K, McMeekin S, Liu H, et al.
Oncol Lett
. 2016 Jun;
12(1):680-686.
PMID: 27347200
The present study aims to quantitatively measure adiposity-related image features and to test the feasibility of applying multivariate statistical data analysis-based prediction models to generate a novel clinical marker and...
4.
Srivastava A, Babu A, Filant J, Moxley K, Ruskin R, Dhanasekaran D, et al.
J Biomed Nanotechnol
. 2016 Jun;
12(6):1159-73.
PMID: 27319211
The bottleneck in current vector-based cancer therapy is the targeted and controlled release of therapeutics in tumors. Exosomes are submicron-sized vesicles that are secreted by all cell types and are...
5.
Dao F, Schlappe B, Tseng J, Lester J, Nick A, Lutgendorf S, et al.
Gynecol Oncol
. 2016 Mar;
141(2):260-263.
PMID: 26968641
Objective: High-grade serous carcinoma (HGSC) generally presents at an advanced stage with poor long-term (LT) survival. Here we describe clinical features found in women surviving HGSC for ten or more...
6.
Qiu Y, Tan M, McMeekin S, Thai T, Ding K, Moore K, et al.
Acta Radiol
. 2015 Dec;
57(9):1149-55.
PMID: 26663390
Background: In current clinical trials of treating ovarian cancer patients, how to accurately predict patients' response to the chemotherapy at an early stage remains an important and unsolved challenge. Purpose:...
7.
Linehan W, Spellman P, Ricketts C, Creighton C, Fei S, Davis C, et al.
N Engl J Med
. 2015 Nov;
374(2):135-45.
PMID: 26536169
Background: Papillary renal-cell carcinoma, which accounts for 15 to 20% of renal-cell carcinomas, is a heterogeneous disease that consists of various types of renal cancer, including tumors with indolent, multifocal...
8.
Chakraborty P, Xiong X, Mustafi S, Saha S, Dhanasekaran D, Mandal N, et al.
Oncotarget
. 2015 Oct;
6(35):37367-84.
PMID: 26452259
Elevated lipid metabolism is implicated in poor survival in ovarian cancer (OC) and other cancers; however, current lipogenesis-targeting strategies lack cancer cell specificity. Here, we identify a novel role of...
9.
McMeekin S, Dizon D, Barter J, Scambia G, Manzyuk L, Lisyanskaya A, et al.
Gynecol Oncol
. 2015 May;
138(1):18-23.
PMID: 25925990
Objective: The purpose of this multicenter, open label, randomized phase III study was to determine whether ixabepilone resulted in improved overall survival (OS) compared with commonly used single-agent chemotherapy (doxorubicin...
10.
Srivastava A, Filant J, Moxley K, Sood A, McMeekin S, Ramesh R
Curr Gene Ther
. 2014 Dec;
15(2):182-92.
PMID: 25537774
Exosomes are 30-100 nm bodies secreted from almost all types of cells into the extracellular spaces. They enclose in their lumen active genetic information in the form of messenger RNA...